Cargando…

Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma

Rationale: To assess treatment effects of 4 complementary miRNAs (miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21) encapsulated in a biodegradable PLGA-PEG nanoparticle, administered by an ultrasound-guided microbubble-mediated targeted delivery (UGMMTD) approach in mouse models of hepatocellular car...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Huaijun, Hu, Zhongqian, Sukumar, Uday Kumar, Bose, Rajendran JC, Telichko, Arsenii, Dahl, Jeremy J, Paulmurugan, Ramasamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671967/
https://www.ncbi.nlm.nih.gov/pubmed/34976581
http://dx.doi.org/10.7150/ntno.63320
_version_ 1784615259999305728
author Wang, Huaijun
Hu, Zhongqian
Sukumar, Uday Kumar
Bose, Rajendran JC
Telichko, Arsenii
Dahl, Jeremy J
Paulmurugan, Ramasamy
author_facet Wang, Huaijun
Hu, Zhongqian
Sukumar, Uday Kumar
Bose, Rajendran JC
Telichko, Arsenii
Dahl, Jeremy J
Paulmurugan, Ramasamy
author_sort Wang, Huaijun
collection PubMed
description Rationale: To assess treatment effects of 4 complementary miRNAs (miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21) encapsulated in a biodegradable PLGA-PEG nanoparticle, administered by an ultrasound-guided microbubble-mediated targeted delivery (UGMMTD) approach in mouse models of hepatocellular carcinoma (HCC). Methods: In vitro apoptotic index was measured in HepG2 and Hepa1-6 HCC cells treated with various combinations of the 4 miRNAs with doxorubicin. Three promising combinations were further tested in vivo by using UGMMTD. 63 HepG2 xenografts in mice were randomized into: group 1, miRNA-122/antimiRNA-10b/antimiRNA-21/US/doxorubicin; group 2, miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21/US/doxorubicin; group 3, miRNA-100/miRNA-122/antimiRNA-10b/US/doxorubicin; group 4, miRNA-122/anitmiRNA-10b/antimiRNA-21/doxorubicin; group 5, miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21/doxorubicin; group 6, miRNA-100/miRNA-122/antimiRNA-10b/doxorubicin; group 7, doxorubicin only treatment; and group 8, without any treatment. Tumor volumes were measured through 18 days. H&E staining, TUNEL assay, and qRT-PCR quantification for delivered miRNAs were performed. Results: In vivo results showed that UGMMTD of miRNAs with doxorubicin in groups 1-3 significantly (P<0.05) delayed tumor growth compared to control without any treatment, and doxorubicin only from day 7 to 18. On qRT-PCR, levels of delivered miRNAs were significantly (P<0.05) higher in groups 1-3 upon UGMMTD treatment compared to controls. TUNEL assay showed that upon UGMMTD, significantly higher levels of apoptotic cell populations were observed in groups 1-3 compared to controls. Toxicity was not observed in various organs of different groups. Conclusions: UGMMTD of miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21 combination improved therapeutic outcome of doxorubicin chemotherapy in mouse models of HCC by substantial inhibition of tumor growth and significant increase in apoptotic index.
format Online
Article
Text
id pubmed-8671967
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Ivyspring International Publisher
record_format MEDLINE/PubMed
spelling pubmed-86719672022-01-01 Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma Wang, Huaijun Hu, Zhongqian Sukumar, Uday Kumar Bose, Rajendran JC Telichko, Arsenii Dahl, Jeremy J Paulmurugan, Ramasamy Nanotheranostics Research Paper Rationale: To assess treatment effects of 4 complementary miRNAs (miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21) encapsulated in a biodegradable PLGA-PEG nanoparticle, administered by an ultrasound-guided microbubble-mediated targeted delivery (UGMMTD) approach in mouse models of hepatocellular carcinoma (HCC). Methods: In vitro apoptotic index was measured in HepG2 and Hepa1-6 HCC cells treated with various combinations of the 4 miRNAs with doxorubicin. Three promising combinations were further tested in vivo by using UGMMTD. 63 HepG2 xenografts in mice were randomized into: group 1, miRNA-122/antimiRNA-10b/antimiRNA-21/US/doxorubicin; group 2, miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21/US/doxorubicin; group 3, miRNA-100/miRNA-122/antimiRNA-10b/US/doxorubicin; group 4, miRNA-122/anitmiRNA-10b/antimiRNA-21/doxorubicin; group 5, miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21/doxorubicin; group 6, miRNA-100/miRNA-122/antimiRNA-10b/doxorubicin; group 7, doxorubicin only treatment; and group 8, without any treatment. Tumor volumes were measured through 18 days. H&E staining, TUNEL assay, and qRT-PCR quantification for delivered miRNAs were performed. Results: In vivo results showed that UGMMTD of miRNAs with doxorubicin in groups 1-3 significantly (P<0.05) delayed tumor growth compared to control without any treatment, and doxorubicin only from day 7 to 18. On qRT-PCR, levels of delivered miRNAs were significantly (P<0.05) higher in groups 1-3 upon UGMMTD treatment compared to controls. TUNEL assay showed that upon UGMMTD, significantly higher levels of apoptotic cell populations were observed in groups 1-3 compared to controls. Toxicity was not observed in various organs of different groups. Conclusions: UGMMTD of miRNA-100/miRNA-122/antimiRNA-10b/antimiRNA-21 combination improved therapeutic outcome of doxorubicin chemotherapy in mouse models of HCC by substantial inhibition of tumor growth and significant increase in apoptotic index. Ivyspring International Publisher 2022-01-01 /pmc/articles/PMC8671967/ /pubmed/34976581 http://dx.doi.org/10.7150/ntno.63320 Text en © The author(s) https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
spellingShingle Research Paper
Wang, Huaijun
Hu, Zhongqian
Sukumar, Uday Kumar
Bose, Rajendran JC
Telichko, Arsenii
Dahl, Jeremy J
Paulmurugan, Ramasamy
Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
title Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
title_full Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
title_fullStr Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
title_full_unstemmed Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
title_short Ultrasound-Guided Microbubble-Mediated Locoregional Delivery of Multiple MicroRNAs Improves Chemotherapy in Hepatocellular Carcinoma
title_sort ultrasound-guided microbubble-mediated locoregional delivery of multiple micrornas improves chemotherapy in hepatocellular carcinoma
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8671967/
https://www.ncbi.nlm.nih.gov/pubmed/34976581
http://dx.doi.org/10.7150/ntno.63320
work_keys_str_mv AT wanghuaijun ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma
AT huzhongqian ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma
AT sukumarudaykumar ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma
AT boserajendranjc ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma
AT telichkoarsenii ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma
AT dahljeremyj ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma
AT paulmuruganramasamy ultrasoundguidedmicrobubblemediatedlocoregionaldeliveryofmultiplemicrornasimproveschemotherapyinhepatocellularcarcinoma